Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Zealand threat over 1080 use

The New Zealand authorities are investigating a threat to contaminate infant formula with the vertebrate control agent, sodium fluoroacetate (also known as 1080), aimed at forcing a stop to its use in pest control. Anonymous letters were received by Federated Farmers and the dairy firm, Fonterra, in November 2014 accompanied by small packages of milk powder containing 1080, the New Zealand police have revealed. The letters threatened to contaminate infant and other formula with 1080 unless New Zealand stopped using 1080 for pest control by the end of March. The case has been under investigation since then. "Whilst there is a possibility that this threat is a hoax, we must treat the threat seriously and a priority investigation is under way," says deputy commissioner (national operations) Mike Clement. Testing of over 40,000 raw milk and product samples has found no detections of 1080, the Ministry of Primary Industries points out.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG022005

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel